BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24877765)

  • 21. The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome.
    Yan W; Huang L
    Int J Pharm; 2009 Feb; 368(1-2):56-62. PubMed ID: 18992312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine.
    Lin CT; Yen CF; Shaw SW; Yen TC; Chen YJ; Soong YK; Lai CH
    Vaccine; 2009 Dec; 27(52):7352-8. PubMed ID: 19781679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes.
    Zhou F; Huang L
    Vaccine; 1993; 11(11):1139-44. PubMed ID: 8249434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of human papillomavirus oncogene-specific CD8 T-cell effector responses in the genital mucosa of vaccinated mice.
    Decrausaz L; Revaz V; Bobst M; Corthésy B; Romero P; Nardelli-Haefliger D
    Int J Cancer; 2010 May; 126(10):2469-78. PubMed ID: 19816937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
    Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC
    Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
    Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
    Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporation of the TLR4 agonist monophosphoryl lipid A into the bilayer of DDA/TDB liposomes: physico-chemical characterization and induction of CD8+ T-cell responses in vivo.
    Nordly P; Agger EM; Andersen P; Nielsen HM; Foged C
    Pharm Res; 2011 Mar; 28(3):553-62. PubMed ID: 21042837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor regression in mice following vaccination with human papillomavirus E7 recombinant protein in PROVAX.
    Hariharan K; Braslawsky G; Barnett RS; Berquist LG; Huynh T; Hanna N; Black A
    Int J Oncol; 1998 Jun; 12(6):1229-35. PubMed ID: 9592179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge.
    Pal S; Tifrea DF; Follmann F; Andersen P; de la Maza LM
    Vaccine; 2017 Mar; 35(13):1705-1711. PubMed ID: 28238632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice.
    Mauch C; Grimm C; Meckel S; Wands JR; Blum HE; Roggendorf M; Geissler M
    Vaccine; 2001 Oct; 20(1-2):170-80. PubMed ID: 11567762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.
    Davidsen J; Rosenkrands I; Christensen D; Vangala A; Kirby D; Perrie Y; Agger EM; Andersen P
    Biochim Biophys Acta; 2005 Dec; 1718(1-2):22-31. PubMed ID: 16321607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo.
    Nordly P; Korsholm KS; Pedersen EA; Khilji TS; Franzyk H; Jorgensen L; Nielsen HM; Agger EM; Foged C
    Eur J Pharm Biopharm; 2011 Jan; 77(1):89-98. PubMed ID: 20940050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple but effective cancer vaccine consisting of an antigen and a cationic lipid.
    Chen W; Yan W; Huang L
    Cancer Immunol Immunother; 2008 Apr; 57(4):517-30. PubMed ID: 17724588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine.
    Yan W; Chen W; Huang L
    J Control Release; 2008 Aug; 130(1):22-8. PubMed ID: 18554742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity.
    Salem ML; Kadima AN; Cole DJ; Gillanders WE
    J Immunother; 2005; 28(3):220-8. PubMed ID: 15838378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu.
    Salem ML; El-Naggar SA; Kadima A; Gillanders WE; Cole DJ
    Vaccine; 2006 Jun; 24(24):5119-32. PubMed ID: 16704888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigen chemically coupled to the surface of liposomes are cross-presented to CD8+ T cells and induce potent antitumor immunity.
    Taneichi M; Ishida H; Kajino K; Ogasawara K; Tanaka Y; Kasai M; Mori M; Nishida M; Yamamura H; Mizuguchi J; Uchida T
    J Immunol; 2006 Aug; 177(4):2324-30. PubMed ID: 16887993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors.
    Aranda F; Llopiz D; Díaz-Valdés N; Riezu-Boj JI; Bezunartea J; Ruiz M; Martínez M; Durantez M; Mansilla C; Prieto J; Lasarte JJ; Borrás-Cuesta F; Sarobe P
    Cancer Res; 2011 May; 71(9):3214-24. PubMed ID: 21402711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes.
    Takagi A; Matsui M; Ohno S; Duan H; Moriya O; Kobayashi N; Oda H; Mori M; Kobayashi A; Taneichi M; Uchida T; Akatsuka T
    Clin Vaccine Immunol; 2009 Oct; 16(10):1383-92. PubMed ID: 19675224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.
    Korsholm KS; Karlsson I; Tang ST; Brandt L; Agger EM; Aagaard C; Andersen P; Fomsgaard A
    PLoS One; 2013; 8(5):e63575. PubMed ID: 23691069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.